DECISION OF THE EEA JOINT COMMITTEE

No 226/2017

of 15 December 2017

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/1634]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2017/1273 of 14 July 2017 approving active chlorine released from sodium hypochlorite as an existing active substance for use in biocidal products of product-types 1, 2, 3, 4 and 5 (1) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2017/1274 of 14 July 2017 approving active chlorine released from calcium hypochlorite as an existing active substance for use in biocidal products of product-types 2, 3, 4 and 5 (2) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2017/1275 of 14 July 2017 approving active chlorine released from chlorine as an existing active substance for use in biocidal products of product-types 2 and 5 (3) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Regulation (EU) 2017/1276 of 14 July 2017 approving peracetic acid generated from tetraacetylethylenediamine and sodium percarbonate as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (4) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Regulation (EU) 2017/1277 of 14 July 2017 approving 2-octyl-isothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 8 (5) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Regulation (EU) 2017/1278 of 14 July 2017 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 11 (6) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Decision (EU) 2017/1282 of 14 July 2017 not approving 2-methyl-1,2-benzisothiazol-3(2H)-one as an active substance for use in biocidal products of product-type 13 (7) is to be incorporated into the EEA Agreement.

(8) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 2 The texts of Implementing Regulations (EU) 2017/1273, (EU) 2017/1274, (EU) 2017/1275, (EU) 2017/1276, (EU) 2017/1277 and (EU) 2017/1278 and Implementing Decision (EU) 2017/1282 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3 This Decision shall enter into force on 16 December 2017, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 15 December 2017. For the EEA Joint Committee The President Sabine MONAUNI

(1) OJ L 184, 15.7.2017, p. 13.

(2) OJ L 184, 15.7.2017, p. 17.

(3) OJ L 184, 15.7.2017, p. 21.

(4) OJ L 184, 15.7.2017, p. 24.

(5) OJ L 184, 15.7.2017, p. 27.

(6) OJ L 184, 15.7.2017, p. 30.

(7) OJ L 184, 15.7.2017, p. 69.

(*1) No constitutional requirements indicated.